Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Herrmann

Showing results (511-520 of 515) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 515 results.
Cancer Cell|December 8, 2009
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumorsMichael Hedvat, Dennis Huszar, Andreas Herrmann, et al.
Clinical Therapeutics|February 7, 2026
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19Maddalena Marconato, Christopher Hackenbruch, Simon Jäger, et al.
Nature Nanotechnology|April 2, 2020
Phage capsid nanoparticles with defined ligand arrangement block influenza virus entryDaniel Lauster, Simon Klenk, Kai Ludwig, et al.
Advanced Healthcare Materials|June 13, 2023
Transformative Materials to Create 3D Functional Human Tissue Models In Vitro in a Reproducible MannerJose L Gerardo-Nava, Jitske Jansen, Daniel Günther, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 18, 2025
Microbubble Shell Stiffness Engineering Enhances Ultrasound Imaging, Drug Delivery, and SonoporationRoman A Barmin, MirJavad Moosavifar, Elena Rama, et al.
Pageof 52

Showing results (511-520 of 515) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 515 results.
Cancer Cell|December 8, 2009
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumorsMichael Hedvat, Dennis Huszar, Andreas Herrmann, et al.
Clinical Therapeutics|February 7, 2026
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19Maddalena Marconato, Christopher Hackenbruch, Simon Jäger, et al.
Nature Nanotechnology|April 2, 2020
Phage capsid nanoparticles with defined ligand arrangement block influenza virus entryDaniel Lauster, Simon Klenk, Kai Ludwig, et al.
Advanced Healthcare Materials|June 13, 2023
Transformative Materials to Create 3D Functional Human Tissue Models In Vitro in a Reproducible MannerJose L Gerardo-Nava, Jitske Jansen, Daniel Günther, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 18, 2025
Microbubble Shell Stiffness Engineering Enhances Ultrasound Imaging, Drug Delivery, and SonoporationRoman A Barmin, MirJavad Moosavifar, Elena Rama, et al.
Pageof 52